1. CDC:
  2. Settipane, Russell A. “Epidemiology of vasomotor rhinitis.” The World Allergy Organization Journal 2.6 (2009): 115.
  3. Accessed November 15, 2017.
  4. Nasal Corticosteroid Sprays, U.S. National Library of Medicine. Accessed November 15, 2017.
  5. Prescribing information for: Sudafed 63D0DF®, Sinex™ Severe Nasal Spray, Atrovent® HFA, Flonase®
  6. Adverse events were those usually associated with post-cryosurgery in the nasal passageway and included: pain/discomfort, headache, facial pain, bleeding, dry nose, ear blockage. By day 90, symptoms had either resolved or were rated as mild.
  7. K162608, Data on File: A2014-02 Clinical Report, Arrinex.
  8. Hwang P, et al. “Cryosurgical Posterior Nasal Tissue Ablation for the Treatment of Rhinitis.” Int Forum Allergy Rhinol. 2017 Oct;7(10):952-956.
  9. Cooper SM, Dawber RP. The history of cryosurgery. J R Soc Med. Apr;94.4 (2001):196-201.
  10. Sunderland S. “Nerves and Nerve Injuries.” Edinburgh & London: Livingstone (1968): 180
  11. Gage AA, Baust JM, Baust JG. “Experimental cryosurgery investigations in vivo.” Cryobiology 59 (2009):229-243.
  12. Leila R, Raluca P, Yves DG, Dirk S, Bruno S. Cryoablation Versus Radiofrequency Ablation in AVNRT: Same Goal, Different Strategy. Journal of Atrial Fibrillation. 2015;8(1):1220.
  13. Hsu M (2014) Significance of Clinical Treatments on Peripheral Nerve and its Effect on Nerve Regeneration. J Neurol Disord 2: 168.
  14. Brain DJ. “Cryosurgery in benign conditions of the nose and throat.” Proc Roy Soc Med 67 (1974): 72-76
  15. Kellerhals B, Schlageter J. “Cryosurgery in vasomotor rhinopathy: experimental histopathology.” ORL 38 (1976): 157-163.